Abstract: The present invention provides phosphoramidate derivatives of a furanosyluracil analog, FAU, that can effectively deliver FAU monophosphate, or a derivative thereof, intracellularly. FAU-Phosphoramidate diesters can bypass the first step of phosphorylation and be activated intracellularly so as to be converted to nucleoside monophosphates. This results in improved formation of nucleoside triphosphates, and higher incorporation into DNA. The compounds of the invention can be used to treat cancer.
Type:
Grant
Filed:
November 9, 2006
Date of Patent:
February 15, 2011
Assignee:
Wayne State University
Inventors:
Anthony F. Shields, Jiri Zemlicka, Sridhar Nimmagadda